Other

Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10

CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 3.6% to $4.70B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $4.83B to $4.70B.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2019
Last reportedQ3 2025
Metric ID: other_available_for_sale_securities_debt_maturities_afte_0f7586

Historical Data

12 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$5.13B$5.03B$4.98B$4.63B$4.41B$4.28B$4.59B$4.42B$4.83B$4.42B$4.53B$4.70B
QoQ Change-1.9%-1.0%-7.1%-4.7%-2.9%+7.2%-3.7%+9.2%-8.4%+2.5%+3.6%
YoY Change-9.8%-12.4%-14.1%-0.8%+0.3%+12.8%-3.6%+2.6%-2.7%
Range$4.28B$5.13B
CAGR-3.1%
Avg YoY Growth-3.1%
Median YoY Growth-2.7%
Current Streak2 quarters growth

Frequently Asked Questions

What is CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10?
CVS Health (CVS) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 of $4.70B in Q3 2025.
How has CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 changed year-over-year?
CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 decreased by 2.7% year-over-year, from $4.83B to $4.70B.